14-103127400-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006291.4(TNFAIP2):c.631G>A(p.Glu211Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000387 in 1,549,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006291.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFAIP2 | NM_006291.4 | c.631G>A | p.Glu211Lys | missense_variant | 3/12 | ENST00000560869.6 | NP_006282.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFAIP2 | ENST00000560869.6 | c.631G>A | p.Glu211Lys | missense_variant | 3/12 | 5 | NM_006291.4 | ENSP00000452634 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000927 AC: 14AN: 151080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000395 AC: 6AN: 151914Hom.: 0 AF XY: 0.0000477 AC XY: 4AN XY: 83806
GnomAD4 exome AF: 0.0000322 AC: 45AN: 1398474Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 19AN XY: 691746
GnomAD4 genome AF: 0.0000992 AC: 15AN: 151176Hom.: 0 Cov.: 33 AF XY: 0.000149 AC XY: 11AN XY: 73848
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.631G>A (p.E211K) alteration is located in exon 2 (coding exon 2) of the TNFAIP2 gene. This alteration results from a G to A substitution at nucleotide position 631, causing the glutamic acid (E) at amino acid position 211 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at